Multinational tobacco company Philip Morris International reportedly is analyzing the marijuana industry for its market possibilities in pharmaceutical and consumer plays with a focus on smoke-free products.

Philip Morris hasn’t ventured specifically into the cannabis space, unlike British American Tobacco and Altria Group which have both taken stakes in marijuana companies. Philip Morris invested $20 million five years ago into Israeli company Syqe Medical to develope an inhaler that allows medical marijuana and other therapeutic products to be delivered in precise doses.

Philip Morris indicated that it is looking at potential market opportunities of cannabis wellness products that help people sleep, calm anxieties and boost energy.

Show Notes:
Tobacco giant Philip Morris eyes marijuana market opportunities
https://mjbizdaily.com/tobacco-giant-philip-morris-eyes-marijuana-market-opportunities/

Guest:
Katrina Glogowski, Seattle Attorney & Angel Investor
https://www.linkedin.com/in/katrina-glogowski-711a985/

Host:
Josh Kincaid, Capital Markets Analyst & host of your cannabis business podcast.
https://www.linkedin.com/in/joshkincaid/

Episode 712 of The Talking Hedge:
Your Cannabis Business Podcast.
​Covering cannabis products, reviews, business news, interviews, investments, events, and more.
https://www.theTalkingHedgepodcast.com

Music Info:
Song: Beat | Keep On | 2020
Artist: Milochromatic Beats
&
Song: Dark Trap Beats Hard Rap Instrumental | Gang | 2018
Artist: LuxrayBeats

Keywords:
Hemp News, Weed News, Cannabis News, Marijuana News, Cannabis Business, Marijuana Business, Cannabis Industry News, Marijuana Industry News, Weed News 420, Talking Hedge Podcast, Cannabis Podcast, Marijuana Podcast, Business Podcast, CBD podcast, THC podcast, Cannabis Pitch Deck, Marijuana Pitch Deck, Marijuana Investment Deck, Cannabis Investment Deck, Cannabis Compliance, Cannabis Data, Cannabis Banking, Cannabis Investment, Pot Stocks, Cannabis Stocks, Weed Stocks, Marijuana Stocks, Cannabis Data, Marijuana Data, Cannabis Analytics, Marijuana Analytics, Cannabis Sales Data, Marijuana Sales Data

Josh is not an investment adviser. The Talking Hedge is long gold and silver. Listeners should always speak to their personal financial advisers.